No excess mortality risk for 10-years survivors after high dose therapy with autologous stem cell transplantation (HDT‐ASCT) for relapsed/refractory Hodgkin's lymphoma (HL)
Autor: | Smeland, Knut Bjøro, Kiserud, Cecilie E, Loge, Jon Håvard, Kolstad, Arne, Fosså, Alexander, Fagerli, Unn Merete, Falk, Ragnhild Sørum, Lauritzsen, Grete F, Oystein Fluge, Maisenhølder, Martin, Kvaløy, Stein, Holte, Harald |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2014 |
DOI: | 10.13140/2.1.1727.8723 |
Databáze: | OpenAIRE |
Externí odkaz: |